149 related articles for article (PubMed ID: 26310237)
1. A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas.
Murray S; Ha MN; Thompson K; Hart RD; Rajaraman M; Snow SL
J Otolaryngol Head Neck Surg; 2015 Aug; 44(1):30. PubMed ID: 26310237
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
3. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification models in human papillomavirus-associated oropharyngeal squamous cell carcinoma: the Nova Scotia distribution.
Forner D; Rigby MH; Wilke D; Taylor SM; Lamond N
J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):3. PubMed ID: 30642398
[TBL] [Abstract][Full Text] [Related]
6. Salvage surgery for recurrent oropharyngeal cancer: post-operative oncologic and functional outcomes.
Culié D; Benezery K; Chamorey E; Ettaiche M; Fernandez J; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Sudaka A; Haudebourg J; Demard F; Santini J; Peyrade F; Dassonville O; Bozec A
Acta Otolaryngol; 2015; 135(12):1323-9. PubMed ID: 26223741
[TBL] [Abstract][Full Text] [Related]
7. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
Rosenquist K; Wennerberg J; Annertz K; Schildt EB; Hansson BG; Bladström A; Andersson G
Acta Otolaryngol; 2007 Sep; 127(9):980-7. PubMed ID: 17712679
[TBL] [Abstract][Full Text] [Related]
8. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
9. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
10. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, Clinicopathological Characteristics, and Outcome of Human Papillomavirus-Associated Oropharyngeal Cancer in Southern Chinese Patients.
Lam EW; Chan JY; Chan AB; Ng CS; Lo ST; Lam VS; Chan MM; Ngai CM; Vlantis AC; Ma RK; Chan PK
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):165-73. PubMed ID: 26604268
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
[TBL] [Abstract][Full Text] [Related]
13. Functional and oncological results of non-surgical vs surgical treatment in squamous cell carcinomas of the oropharynx.
Díaz-Molina JP; Rodrigo JP; Alvarez-Marcos C; Blay P; de la Rúa A; Estrada E; Alonso R
Acta Otorrinolaringol Esp; 2012; 63(5):348-54. PubMed ID: 22503508
[TBL] [Abstract][Full Text] [Related]
14. Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study.
Culié D; Viotti J; Modesto A; Schiappa R; Chamorey E; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Ramay AS; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Bozec A
Eur J Surg Oncol; 2021 Feb; 47(2):367-374. PubMed ID: 33004271
[TBL] [Abstract][Full Text] [Related]
15. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
Lacy PD; Spitznagel EL; Piccirillo JF
Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
[TBL] [Abstract][Full Text] [Related]
16. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
[TBL] [Abstract][Full Text] [Related]
17. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma.
Self EM; Bumpous J; Ziegler C; Wilson L; Potts K
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):356-61. PubMed ID: 23599070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
